Hub : Traits :

Pulse rate

336 significantly associated models · 108 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	207814451	208331649	1	1	1.5e-07	1.8e-19	1.8e-13	33	CD34
2	2	17446185	18230779	2	2	3.5e-08	1.9e-09	1.0e-01	93	RAD51AP2 SMC6
3	2	27467598	27949052	1	1	1.8e-10	1.1e-09	1.0e+00	100	FNDC4
4	2	178362572	179939959	2	2	6.3e-10	6.3e-41	2.1e-29	29	OSBPL6 TTN
5	3	48012797	51043528	22	1	1.0e-09	2.0e-08	6.1e-03	76	TRAIP
6	3	52565100	53985919	1	1	1.4e-07	9.2e-08	6.8e-03	74	TKT
7	3	140350567	141867638	1	1	6.7e-08	1.8e-08	1.0e+00	100	ZBTB38
8	5	122434666	123002130	1	1	1.1e-07	4.3e-07	7.2e-02	87	CEP120
9	5	136386984	138474788	5	2	7.8e-11	7.8e-11	1.0e+00	100	REEP2 RP11-381K20.5
10	6	118089396	119949791	3	2	1.8e-19	2.9e-25	7.5e-04	90	C6orf204 MCM9
11	6	120704438	122457698	3	4	2.2e-17	5.4e-38	1.7e-12	70	C6orf170 GJA1 TBC1D32
12	6	133961374	134468561	1	1	3.3e-08	1.9e-09	7.9e-03	80	TCF21
13	7	99060603	101185166	19	1	1.2e-28	8.2e-26	1.2e-01	98	GIGYF1
14	9	35213538	36597142	2	1	1.5e-09	6.7e-09	1.0e+00	100	LOC158376
15	11	13288698	14975818	1	1	1.3e-07	6.7e-08	1.3e-01	92	SPON1
16	11	60839578	62346131	6	1	1.0e-13	1.1e-13	3.4e-02	92	FADS1
17	11	64700767	65226187	1	1	1.3e-07	4.3e-06	2.1e-01	93	CAPN1
18	12	33480976	34826574	1	2	4.3e-13	4.5e-24	7.1e-11	58	ALG10
19	12	38353816	39998144	1	1	9.1e-08	1.0e-07	1.9e-01	94	CPNE8
20	13	41092698	42640341	2	1	3.2e-09	9.0e-07	7.0e-01	99	NAA16
21	14	20843889	22255090	1	1	1.2e-08	1.9e-15	1.2e-09	41	ARHGEF40
22	14	22670975	24501100	8	6	2.3e-24	1.5e-61	2.0e-21	67	CMTM5 HOMEZ NGDN RBM23 SLC22A17 THTPA
23	14	85303548	86791228	1	1	8.1e-23	1.8e-22	1.0e+00	100	FLRT2
24	15	72287856	74291976	3	3	2.4e-17	3.5e-19	1.1e-05	76	BBS4 HCN4 NEO1
25	17	14714000	16109675	1	1	1.2e-07	8.1e-07	3.1e-06	11	AC005517.3
26	19	38444944	39914308	1	1	4.5e-09	1.9e-09	5.6e-02	90	ACTN4
27	20	35835657	37586842	2	3	1.2e-22	3.7e-51	5.8e-16	71	KIAA1755 VSTM2L
28	22	38192452	39859169	9	1	2.6e-08	4.4e-08	1.0e+00	100	RP3-508I15.9

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Pulse rate, automated reading	38.52	42	41	91.1	0.99	4.5e-38	AC005517.3 ACTN4 ALG10 ARHGEF40 BBS4 C6orf170 C6orf204 CAPN1 CD34 CEP120 CMTM5 CPNE8 FADS1 FLRT2 FNDC4 GIGYF1 GJA1 HCN4 HOMEZ KIAA1755 LOC158376 MCM9 NAA16 NEO1 NGDN OSBPL6 RAD51AP2 RBM23 REEP2 RP11-381K20.5 RP3-508I15.9 SLC22A17 SMC6 SPON1 TBC1D32 TCF21 THTPA TKT TRAIP TTN VSTM2L ZBTB38
Triglycerides	10.31	3	2	4.4	0.00	1.0e+00	BBS4 FADS1 FNDC4
Pulse wave reflection index	5.46	3	1	2.2	-0.99	8.4e-03	HOMEZ KIAA1755 VSTM2L
Height	4.08	17	6	13.3	-0.17	5.1e-01	ALG10 ARHGEF40 BBS4 CAPN1 CEP120 CMTM5 FADS1 FNDC4 GIGYF1 NEO1 NGDN RP3-508I15.9 SMC6 SPON1 TBC1D32 TKT ZBTB38
Standing height	3.84	7	6	13.3	-0.18	7.0e-01	ARHGEF40 CAPN1 CEP120 FADS1 FNDC4 RAD51AP2 ZBTB38
Fasting Glucose	3.83	2	2	4.4	0.00	1.0e+00	FADS1 FNDC4
Trunk predicted mass	3.71	5	5	11.1	-0.48	4.2e-01	ARHGEF40 CAPN1 CEP120 FNDC4 ZBTB38
Trunk fat-free mass	3.69	5	5	11.1	-0.47	4.2e-01	ARHGEF40 CAPN1 CEP120 FNDC4 ZBTB38
Whole body water mass	3.51	6	5	11.1	-0.33	5.2e-01	ARHGEF40 CAPN1 CEP120 FNDC4 VSTM2L ZBTB38
Whole body fat-free mass	3.50	6	5	11.1	-0.32	5.3e-01	ARHGEF40 CAPN1 CEP120 FNDC4 VSTM2L ZBTB38
Gout (self-reported)	3.43	2	1	2.2	0.00	1.0e+00	FNDC4 TKT
Sitting height	3.39	9	5	11.1	-0.12	7.6e-01	ARHGEF40 CEP120 CMTM5 FADS1 FNDC4 KIAA1755 NEO1 VSTM2L ZBTB38
Comparative height size at age 10	3.34	6	4	8.9	-0.05	9.3e-01	ALG10 ARHGEF40 CAPN1 CEP120 FNDC4 ZBTB38
Arm fat-free mass (left)	3.32	5	4	8.9	-0.47	4.2e-01	ARHGEF40 CAPN1 CEP120 FNDC4 ZBTB38
Arm fat-free mass (right)	3.30	6	4	8.9	-0.33	5.2e-01	ARHGEF40 CAPN1 CEP120 FNDC4 VSTM2L ZBTB38
Arm predicted mass (right)	3.29	5	5	11.1	-0.50	3.9e-01	ARHGEF40 CAPN1 CEP120 FNDC4 ZBTB38
Arm predicted mass (left)	3.29	5	4	8.9	-0.48	4.1e-01	ARHGEF40 CAPN1 CEP120 FNDC4 ZBTB38
Basal metabolic rate	3.26	5	5	11.1	-0.45	4.4e-01	ARHGEF40 CAPN1 CEP120 FNDC4 ZBTB38
Alcohol intake frequency.	3.09	2	1	2.2	0.00	1.0e+00	FNDC4 RP3-508I15.9
Leg predicted mass (right)	3.04	6	5	11.1	-0.35	5.0e-01	ARHGEF40 CAPN1 CEP120 FNDC4 VSTM2L ZBTB38
Leg predicted mass (left)	3.03	6	5	11.1	-0.34	5.2e-01	ARHGEF40 CAPN1 CEP120 FNDC4 VSTM2L ZBTB38
Leg fat-free mass (right)	3.03	6	5	11.1	-0.35	5.0e-01	ARHGEF40 CAPN1 CEP120 FNDC4 VSTM2L ZBTB38
Leg fat-free mass (left)	3.02	6	5	11.1	-0.33	5.2e-01	ARHGEF40 CAPN1 CEP120 FNDC4 VSTM2L ZBTB38
High cholesterol (Self-reported)	2.98	2	1	2.2	0.00	1.0e+00	FADS1 FNDC4
Diastolic blood pressure, automated reading	2.97	7	2	4.4	0.96	7.9e-04	AC005517.3 C6orf204 CEP120 GIGYF1 SPON1 TKT TRAIP
Medication: Allopurinol	2.80	1	1	2.2	0.00	1.0e+00	FNDC4
Forced expiratory volume in 1-second (FEV1), predicted	2.49	1	1	2.2	0.00	1.0e+00	ZBTB38
Blood Platelet Count	2.42	7	5	11.1	0.60	1.5e-01	ACTN4 CEP120 FADS1 FNDC4 HCN4 RP3-508I15.9 VSTM2L
Weight	2.33	4	3	6.7	-0.18	8.2e-01	CAPN1 CEP120 FNDC4 ZBTB38
Type 2 Diabetes (T2D) (2018)	2.29	3	1	2.2	0.00	1.0e+00	FNDC4 SMC6 TRAIP
Diabetes diagnosed by doctor	2.25	2	1	2.2	0.00	1.0e+00	FNDC4 SMC6
Medication: Atorvastatin	2.24	1	1	2.2	0.00	1.0e+00	FNDC4
LDL Cholesterol	2.20	2	1	2.2	0.00	1.0e+00	FADS1 FNDC4
Medication: Cholesterol lowering	2.18	2	1	2.2	0.00	1.0e+00	FNDC4 TCF21
Blood Red Count	2.14	10	9	20.0	0.62	5.7e-02	BBS4 C6orf170 FADS1 FNDC4 GIGYF1 GJA1 NAA16 TKT TRAIP ZBTB38
Chronotype (morning person)	2.12	2	2	4.4	0.00	1.0e+00	ALG10 CPNE8
HDL Cholesterol	2.10	1	1	2.2	0.00	1.0e+00	FADS1
Heel T-Score	2.00	8	7	15.6	0.25	5.1e-01	C6orf204 CEP120 FADS1 GIGYF1 GJA1 RP3-508I15.9 TRAIP ZBTB38
Medication: Seretide 50 evohaler	1.99	1	0	0.0	0.00	1.0e+00	GJA1
Angina (self-reported)	1.97	1	1	2.2	0.00	1.0e+00	TCF21
Medication: Metformin	1.96	1	1	2.2	0.00	1.0e+00	FNDC4
Cholesterol lowering medication	1.96	1	1	2.2	0.00	1.0e+00	FNDC4
Forced vital capacity (FVC), Best measure	1.94	5	2	4.4	-0.45	4.4e-01	BBS4 CAPN1 CEP120 SPON1 ZBTB38
Alcohol intake versus 10 years previously	1.93	1	1	2.2	0.00	1.0e+00	FNDC4
Angina	1.88	1	1	2.2	0.00	1.0e+00	TCF21
Diabetes (self-reported)	1.85	1	1	2.2	0.00	1.0e+00	FNDC4
Waist Hip Ratio (WHR)	1.81	6	3	6.7	-0.34	4.5e-01	ALG10 REEP2 SLC22A17 TKT TRAIP ZBTB38
Heel bone mineral density (BMD) T-score, automated (right)	1.76	4	1	2.2	-0.11	8.9e-01	ALG10 RP3-508I15.9 TRAIP ZBTB38
Forced vital capacity (FVC)	1.73	4	2	4.4	-0.20	8.0e-01	BBS4 CAPN1 CEP120 ZBTB38
Relative age of first facial hair	1.69	2	1	2.2	0.00	1.0e+00	FNDC4 ZBTB38
Coronary Artery Disease (CAD)	1.68	1	0	0.0	0.00	1.0e+00	TCF21
Trunk fat mass	1.67	4	2	4.4	0.69	3.1e-01	BBS4 CEP120 TRAIP ZBTB38
Forced expiratory volume in 1-second (FEV1), Best measure	1.65	3	2	4.4	-0.83	1.7e-01	CEP120 GJA1 ZBTB38
Medication: Simvastatin	1.61	2	1	2.2	0.00	1.0e+00	FADS1 FNDC4
Hair/balding pattern: Pattern 4	1.61	2	2	4.4	0.00	1.0e+00	FADS1 ZBTB38
Impedance of whole body	1.60	2	2	4.4	0.00	1.0e+00	CEP120 FNDC4
Blood White Count	1.59	6	2	4.4	0.16	7.6e-01	ACTN4 C6orf204 CEP120 FADS1 FNDC4 NAA16
Diabetes (father)	1.58	1	0	0.0	0.00	1.0e+00	FNDC4
Hip circumference	1.58	5	4	8.9	-0.40	5.1e-01	CAPN1 CEP120 FNDC4 RP3-508I15.9 ZBTB38
Ever unenthusiastic/disinterested for a whole week	1.55	1	0	0.0	0.00	1.0e+00	FADS1
Birth weight	1.55	2	0	0.0	0.00	1.0e+00	ARHGEF40 CEP120
Impedance of arm (left)	1.54	3	2	4.4	0.00	1.0e+00	CEP120 FNDC4 REEP2
Crohns Disease (2017)	1.51	3	2	4.4	0.00	1.0e+00	FNDC4 GIGYF1 ZBTB38
Hand grip strength (left)	1.51	2	1	2.2	0.00	1.0e+00	ARHGEF40 ZBTB38
Heel bone mineral density (BMD) T-score, automated (left)	1.50	2	1	2.2	0.00	1.0e+00	RP3-508I15.9 TRAIP
Impedance of leg (left)	1.50	4	3	6.7	0.81	1.9e-01	ARHGEF40 CEP120 FNDC4 VSTM2L
Heart attack/myocardial infarction (self-reported)	1.50	1	0	0.0	0.00	1.0e+00	TCF21
Systolic blood pressure, automated reading	1.47	3	1	2.2	0.00	1.0e+00	HOMEZ RBM23 SLC22A17
Hand grip strength (right)	1.47	3	1	2.2	0.00	1.0e+00	ARHGEF40 GIGYF1 ZBTB38
Schizophrenia (2014)	1.45	2	0	0.0	0.00	1.0e+00	GIGYF1 TKT
Systolic Blood Pressure	1.45	7	2	4.4	-0.23	6.2e-01	CD34 CEP120 FNDC4 HOMEZ NAA16 SLC22A17 TCF21
Heart attack	1.45	1	0	0.0	0.00	1.0e+00	TCF21
Impedance of arm (right)	1.45	3	2	4.4	0.00	1.0e+00	CEP120 FNDC4 REEP2
Forced expiratory volume in 1-second (FEV1)	1.44	2	2	4.4	0.00	1.0e+00	CEP120 ZBTB38
Whole body fat mass	1.44	5	2	4.4	0.59	3.0e-01	BBS4 CEP120 HCN4 TRAIP ZBTB38
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.44	2	0	0.0	0.00	1.0e+00	CEP120 GJA1
Impedance of leg (right)	1.43	4	2	4.4	0.80	2.0e-01	ARHGEF40 CEP120 FNDC4 VSTM2L
Frequency of tenseness / restlessness in last 2 weeks	1.43	1	0	0.0	0.00	1.0e+00	TKT
Waist circumference	1.42	5	3	6.7	0.41	4.9e-01	BBS4 CEP120 FNDC4 HCN4 ZBTB38
Hearing aid user	1.41	1	0	0.0	0.00	1.0e+00	CD34
Lung FEV1/FVC ratio	1.40	8	1	2.2	-0.13	7.4e-01	ACTN4 CEP120 GJA1 RAD51AP2 SLC22A17 SMC6 TCF21 ZBTB38
Ever smoked	1.40	1	0	0.0	0.00	1.0e+00	TRAIP
Birth weight of first child	1.39	1	1	2.2	0.00	1.0e+00	ZBTB38
Bipolar Disorder or Schizophrenia	1.38	2	0	0.0	0.00	1.0e+00	GIGYF1 TKT
Seen a psychiatrist for nerves, anxiety, tension or depression	1.37	1	0	0.0	0.00	1.0e+00	FADS1
Schizophrenia (2018)	1.36	2	0	0.0	0.00	1.0e+00	GIGYF1 TKT
Medication for cholesterol, blood pressure or diabetes	1.34	2	0	0.0	0.00	1.0e+00	FNDC4 TCF21
Cardiovascular Disease	1.32	3	2	4.4	0.00	1.0e+00	FNDC4 NAA16 TCF21
Number of treatments/medications taken	1.32	1	0	0.0	0.00	1.0e+00	FNDC4
Trunk fat percentage	1.32	4	2	4.4	0.91	8.9e-02	BBS4 HCN4 TRAIP ZBTB38
Breast Cancer	1.31	1	1	2.2	0.00	1.0e+00	ZBTB38
Medication: Paracetamol	1.31	1	0	0.0	0.00	1.0e+00	NEO1
Seen doctor (GP) for nerves, anxiety, tension or depression	1.30	1	0	0.0	0.00	1.0e+00	TKT
Number of self-reported non-cancer illnesses	1.30	1	1	2.2	0.00	1.0e+00	FNDC4
Ever had prostate specific antigen (PSA) test	1.30	1	0	0.0	0.00	1.0e+00	ZBTB38
Hypothyroidism (self reported)	1.29	2	0	0.0	0.00	1.0e+00	FADS1 GIGYF1
Overall health rating	1.28	1	0	0.0	0.00	1.0e+00	RP3-508I15.9
Bipolar Disorder (2018)	1.27	1	0	0.0	0.00	1.0e+00	FNDC4
Reaction Time	1.27	1	0	0.0	0.00	1.0e+00	CPNE8
Serious illness, injury or assault to yourself	1.27	1	0	0.0	0.00	1.0e+00	SMC6
Leg fat mass (right)	1.27	5	2	4.4	0.52	3.7e-01	BBS4 CEP120 FNDC4 HCN4 ZBTB38
Allergy or Eczema	1.26	2	1	2.2	0.00	1.0e+00	FNDC4 ZBTB38
Leg fat mass (left)	1.26	5	2	4.4	0.51	3.8e-01	BBS4 CEP120 FNDC4 HCN4 ZBTB38
Illnesses of father: Heart disease	1.25	1	0	0.0	0.00	1.0e+00	TCF21
Asthma (self-reported)	1.25	3	0	0.0	0.00	1.0e+00	FADS1 GJA1 ZBTB38
Average weekly champagne plus white wine intake	1.25	1	0	0.0	0.00	1.0e+00	FADS1
Schizophrenia vs Biploar Disorder	1.24	1	0	0.0	0.00	1.0e+00	FNDC4
Headache pain in last month	1.24	1	0	0.0	0.00	1.0e+00	BBS4
Arm fat mass (left)	1.24	4	3	6.7	0.53	4.7e-01	BBS4 CEP120 FNDC4 ZBTB38
Frequency of tiredness / lethargy in last 2 weeks	1.20	1	0	0.0	0.00	1.0e+00	TRAIP
Lung FVC	1.19	7	3	6.7	0.09	8.4e-01	C6orf204 CAPN1 CD34 CEP120 FADS1 TCF21 ZBTB38
Arm fat mass (right)	1.19	4	2	4.4	0.55	4.5e-01	BBS4 CEP120 FNDC4 ZBTB38
Hypothyroidism/myxoedema (self-reported)	1.19	2	0	0.0	0.00	1.0e+00	FADS1 GIGYF1
Allergy	1.18	1	1	2.2	0.00	1.0e+00	ZBTB38
Fluid intelligence score	1.18	1	0	0.0	0.00	1.0e+00	TKT
Body fat percentage	1.18	5	1	2.2	0.96	8.1e-03	BBS4 HCN4 NEO1 TRAIP ZBTB38
Medication: Bendroflumethiazide	1.18	1	0	0.0	0.00	1.0e+00	TCF21
Hayfever, allergic rhinitis or eczema	1.17	1	1	2.2	0.00	1.0e+00	ZBTB38
Number of live births	1.17	1	0	0.0	0.00	1.0e+00	FADS1
Diabetes (mother)	1.16	1	0	0.0	0.00	1.0e+00	FNDC4
Medication: Amlodipine	1.16	2	0	0.0	0.00	1.0e+00	CD34 TCF21
Medication for cholesterol	1.16	1	1	2.2	0.00	1.0e+00	FNDC4
Neuroticism score	1.15	1	0	0.0	0.00	1.0e+00	SLC22A17
Asthma	1.14	3	0	0.0	0.00	1.0e+00	FADS1 GJA1 ZBTB38
Peak expiratory flow (PEF)	1.14	1	1	2.2	0.00	1.0e+00	TCF21
Mouth/teeth dental problems: Mouth ulcers	1.14	1	0	0.0	0.00	1.0e+00	FADS1
Respiratory disease	1.12	2	1	2.2	0.00	1.0e+00	FADS1 GJA1
Nervous feelings	1.11	1	0	0.0	0.00	1.0e+00	FLRT2
Leg fat percentage (left)	1.11	3	1	2.2	0.00	1.0e+00	BBS4 HCN4 NEO1
Relative age voice broke	1.10	1	0	0.0	0.00	1.0e+00	TRAIP
Illnesses of siblings	1.09	1	0	0.0	0.00	1.0e+00	SMC6
Leg fat percentage (right)	1.09	3	1	2.2	0.00	1.0e+00	BBS4 HCN4 NEO1
Medication: Levothyroxine sodium	1.08	1	0	0.0	0.00	1.0e+00	GIGYF1
Medication: Aspirin	1.08	1	0	0.0	0.00	1.0e+00	TCF21
Neuroticism (Nagel 2018)	1.07	2	0	0.0	0.00	1.0e+00	RP3-508I15.9 TKT
Verbal and Numeric Reasoning (VNR)	1.06	2	1	2.2	0.00	1.0e+00	RAD51AP2 TKT
Neuroticism	1.04	2	0	0.0	0.00	1.0e+00	RP11-381K20.5 SLC22A17
Ever used hormone-replacement therapy (HRT)	1.04	1	0	0.0	0.00	1.0e+00	RP3-508I15.9
Depressed Affect (Nagel 2018)	0.99	1	0	0.0	0.00	1.0e+00	RP3-508I15.9
Worry (Nagel 2018)	0.97	1	0	0.0	0.00	1.0e+00	TKT
Arm fat percentage (left)	0.95	2	1	2.2	0.00	1.0e+00	BBS4 HCN4
Mouth/teeth dental problems: Dentures	0.94	1	0	0.0	0.00	1.0e+00	BBS4
Medication: Blood pressure	0.93	1	0	0.0	0.00	1.0e+00	TCF21
Smoking Status	0.92	1	0	0.0	0.00	1.0e+00	TRAIP
Arm fat percentage (right)	0.90	1	1	2.2	0.00	1.0e+00	BBS4
Vascular/heart problems diagnosed by doctor	0.89	1	1	2.2	0.00	1.0e+00	TCF21
Irritable Bowel Disease (IBD)	0.88	2	1	2.2	0.00	1.0e+00	FNDC4 GIGYF1
Blood Eosinophil Count	0.80	3	2	4.4	0.00	1.0e+00	FADS1 SLC22A17 TRAIP
Intelligence (Savage-Jansen 2018)	0.78	2	0	0.0	0.00	1.0e+00	RAD51AP2 TKT
High blood pressure	0.78	1	0	0.0	0.00	1.0e+00	TCF21
Hypertension (Self-reported)	0.78	1	0	0.0	0.00	1.0e+00	TCF21
BMI	0.77	4	4	8.9	0.31	6.9e-01	BBS4 CEP120 FNDC4 HCN4
Body mass index (BMI)	0.74	3	0	0.0	0.00	1.0e+00	BBS4 CEP120 FNDC4
Qualifications: College or University degree	0.72	1	0	0.0	0.00	1.0e+00	NEO1
Hair Pigment	0.64	5	2	4.4	0.04	9.5e-01	FNDC4 GIGYF1 NEO1 REEP2 ZBTB38
Tanning	0.20	1	1	2.2	0.00	1.0e+00	FNDC4

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Heart Atrial Appendage	8	0.507	2.1
GTEx	Brain Putamen basal ganglia	5	0.801	2.0
GTEx	Ovary	3	0.330	2.0
GTEx	Heart Left Ventricle	6	0.392	1.9
GTEx	Skin Not Sun Exposed Suprapubic	9	0.366	1.9
GTEx	Artery Aorta	7	0.235	1.8
GTEx	Artery Coronary	3	0.254	1.8
GTEx	Artery Tibial	11	0.292	1.8
GTEx	Colon Transverse	6	0.291	1.8
GTEx	Esophagus Gastroesophageal Junction	5	0.346	1.8
GTEx	Esophagus Mucosa	13	0.392	1.8
GTEx	Liver	2	0.279	1.8
GTEx	Muscle Skeletal	9	0.311	1.8
GTEx	Nerve Tibial	18	0.417	1.8
GTEx	Pituitary	4	0.359	1.8
GTEx	Skin Sun Exposed Lower leg	15	0.412	1.8
GTEx	Vagina	2	0.315	1.8
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	2	0.182	1.8
GTEx	Adipose Subcutaneous	8	0.229	1.7
GTEx	Adipose Visceral Omentum	5	0.246	1.7
GTEx	Adrenal Gland	1	0.069	1.7
GTEx	Brain Cerebellar Hemisphere	2	0.134	1.7
GTEx	Brain Cerebellum	4	0.202	1.7
GTEx	Breast Mammary Tissue (Female)	4	0.243	1.7
GTEx	Cells Transformed fibroblasts	9	0.214	1.7
GTEx	Colon Sigmoid	2	0.137	1.7
GTEx	Esophagus Muscularis	5	0.155	1.7
GTEx	Lung	5	0.174	1.7
GTEx	Pancreas	3	0.184	1.7
GTEx	Prostate	2	0.240	1.7
GTEx	Spleen	3	0.213	1.7
GTEx	Stomach	5	0.344	1.7
GTEx	Testis	11	0.349	1.7
GTEx	Thyroid	10	0.250	1.7
GTEx	Uterus	3	0.529	1.7
NTR	Blood	3	0.125	1.7
ROSMAP	Brain Pre-frontal Cortex	13	0.296	1.7
The Cancer Genome Atlas	Breast Invasive Carcinoma	8	0.182	1.7
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	3	0.110	1.7
The Cancer Genome Atlas	Lung Adenocarcinoma	7	0.238	1.7
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	2	0.126	1.7
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	2	0.120	1.7
The Cancer Genome Atlas	Soft Tissue Sarcoma	0	0.000	1.7
The Cancer Genome Atlas	Skin Cutaneous Melanoma	0	0.000	1.7
The Cancer Genome Atlas	Testicular Germ Cell Tumors	4	0.313	1.7
The Cancer Genome Atlas	Thyroid Carcinoma	15	0.291	1.7
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	0	0.000	1.7
GTEx	Brain Caudate basal ganglia	1	0.109	1.6
GTEx	Brain Cortex	0	0.000	1.6
GTEx	Brain Frontal Cortex BA9	0	0.000	1.6
GTEx	Brain Hypothalamus	1	0.169	1.6
GTEx	Brain Nucleus accumbens basal ganglia	3	0.347	1.6
GTEx	Breast Mammary Tissue	5	0.253	1.6
GTEx	Cells EBV-transformed lymphocytes	0	0.000	1.6
GTEx	Small Intestine Terminal Ileum	1	0.217	1.6
GTEx	Whole Blood	6	0.301	1.6
METSIM	Adipose	10	0.217	1.6
YFS	Blood	4	0.087	1.6
CommonMind	Brain Pre-frontal Cortex	10	0.186	1.6
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	1	0.060	1.6
The Cancer Genome Atlas	Colon Adenocarcinoma	5	0.242	1.6
The Cancer Genome Atlas	Esophageal Carcinoma	0	0.000	1.6
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	1	0.024	1.6
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	6	0.293	1.6
The Cancer Genome Atlas	Brain Lower Grade Glioma	3	0.070	1.6
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	2	0.181	1.6
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	3	0.120	1.6
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	1	0.075	1.6
The Cancer Genome Atlas	Prostate Adenocarcinoma	4	0.087	1.6
The Cancer Genome Atlas	Rectum Adenocarcinoma	0	0.000	1.6
The Cancer Genome Atlas	Stomach Adenocarcinoma	0	0.000	1.6
GTEx	Brain Hippocampus	0	0.000	1.5
GTEx	Breast Mammary Tissue (Male)	1	0.084	1.5
The Cancer Genome Atlas	Glioblastoma Multiforme	1	0.098	1.5